#hope to do more

[havockingboo]

Hmmmm……

[this-should-do]

alyx portrait as a break from working on an alyx centric comic :)

[whirlybotart]

Did some centaurworld style headshots for several wonderful TFA ocs! These were super fun to do and I hope to try this art style again with some more art!

@mubthemoff owns the orange green eyed bot with anxiety named Volt <3 @in-love-with-a-singing-plant owns Calypso the adorable bot sitting in between Zipper and Volt! and our insane little red eyed friend below them @woolydemon owns both Zipper and Hum [the more lime green horned fellow beside Radio and the pink gamer who starts the second line <3]

and I own Radio but Im assuming u guys already knew that-

[emjaydoubleyou]

this post is fearmongering. the results of this study are concerning and should definitely be a matter of public discussion, but this is certainly not the conclusion the researchers came to.

the point of the study was to assess the risks of exposure to toxic metals- something one of the co-authors notes are “ubiquitous” fwiw- via menstrual products. Their research confirmed that these metals are indeed present in tampons, but no further conclusions are drawn. it is possible the metal entered into the cotton from the soil, which is a well-known phenomenon; cotton is so good at lifting heavy metals that it has actually been suggested as a part of the solution for revitalizing polluted ground.

the authors conclude with an acknowledgement that the study should be repeated- their sample size was 60 tampons- and a suggestion that further testing ought to be done to indicate whether or not these metals can even leech out of the tampon in the first place, let alone whether or not such leeching could occur at levels deleterious to human health.

there is, in fact, a body of research- too small, for sure, but much larger than this single study- indicating that long-term proper tampon use has no observable negative impact on health. i am grateful and thrilled that more research is being done and i hope that this study is the first of many on this line of questioning, but i am really frustrated at this post and the response it got.

obviously, if this study alters your approach to menstrual health, more power to you. consumers should be informed-risk-takers, and menstrual health is double-obviously a very personal choice. but it definitely wasn't the researchers concluding that you ought to “avoid using tampons at all cost," only this tumblr user did. the lead author of the paper, in fact, specifically says that she hopes people do NOT panic about the results.

(the notes of the post were disappointing. people affirming that they knew they were right to be suspicious of tampons all along, or even recommending alternatives that actually have very little to no research regarding the safety of long-term use, etc. it’s a different conversation, but categorical distrust of tampons is old-school misogyny. you certainly shouldn't wear them if you don’t want to, but there is nothing inherently scary or wrong about them, and people who prefer them are not being reckless or crass.)

((if you're really worried about exposure to heavy metals, you may want to turn a critical eye to fast fashion, as an aside))

[sergle]

the threshold has been crossed, it is now springtime!!

[eydilily]

would you bite the hand that feeds you?

[chloesimaginationthings]

How Jax found Gangle’s figure collection in TADC,,

[ruushes]

companions re-classed part 3 - shadowheart 🌌🌚🌝

*shadowdancer isn't a 5e rogue subclass, it's a 3.5e rogue-based prestige class, but it suits her so well and when i played 3.5e as a kid i thought it was the coolest thing ever lol so i wanted to use it

karlach 🔥 wyll ⚔️

[vita-divata]

Getting ready for bed~

[marsipain]

Norwegian Mikus :)

Left is Miku as a russ and right is Miku in a bunad!

[reasonsforhope]

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of participants in a study no longer requiring insulin therapy. The treatment was safe and well-tolerated, and further trials are planned to confirm these results.

Groundbreaking research presented at UEG Week 2024 introduces a promising new treatment approach for type 2 diabetes (T2D) that has the potential to greatly reduce or even eliminate the need for insulin therapy.

This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of patients.

Globally, T2D affects 422 million people... While insulin therapy is commonly used to manage blood sugar levels in T2D patients, it can result in side effects... and further complicate diabetes management. [Note: Also very importantly it's fucking bankrupting people who need it!!] A need therefore exists for alternative treatment strategies.

Study Design and Outcomes

The first-in-human study included 14 participants aged 28 to 75 years, with body mass indices ranging from 24 to 40 kg/m². Each participant underwent the ReCET procedure under deep sedation, a treatment intended to improve the body’s sensitivity to its own insulin. Following the procedure, participants adhered to a two-week isocaloric liquid diet, after which semaglutide was gradually titrated up to 1mg/week.

Remarkably, at the 6- and 12-month follow-up, 86% of participants (12 out of 14) no longer required insulin therapy, and this success continued through the 24-month follow-up. In these cases, all patients maintained glycaemic control, with HbA1c levels remaining below 7.5%.

Tolerability and Safety

The maximum dose of semaglutide was well-tolerated by 93% of participants, one individual could not increase to the maximum dose due to nausea. All patients successfully completed the ReCET procedure, and no serious adverse effects were reported.

Dr Celine Busch, lead author of the study, commented, “These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with semaglutide, can effectively eliminate the need for insulin therapy.”

“Unlike drug therapy, which requires daily medication adherence, ReCET is compliance-free [meaning: you don't have to take it every day], addressing the critical issue of ongoing patient adherence in the management of T2D. In addition, the treatment is disease-modifying: it improves the patient’s sensitivity to their own (endogenous) insulin, tackling the root cause of the disease, as opposed to currently available drug therapies, that are at best disease-controlling.”

Looking ahead, the researchers plan to conduct larger randomized controlled trials to further validate these findings. Dr. Busch added, “We are currently conducting the EMINENT-2 trial with the same inclusion and exclusion criteria and administration of semaglutide, but with either a sham procedure or ReCET. This study will also include mechanistic assessments to evaluate the underlying mechanism of ReCET.”

-via SciTechDaily, October 17, 2024

--

Note: If it works even half as well as suggested, this could free so many people from the burden of the ongoing ridiculous cost of insulin. Pharma companies that make insulin can go choke (hopefully).

[xxplastic-cubexx]

brain please wake up and draw

bonus :

[egophiliac]

doylist explanation for why Gidel is only in Fellow's non-idle lesson animations: probably something about space constraints and making sure two sprites in one seat aren't covering anyone else when they're not in focus

watsonian explanation for why Gidel is only in Fellow's non-idle lesson animations: he snuck in and is hiding from the teachers, don't give him away 🤫

(I've reached my limit of unsuccessful attempts at pulling them before I need to save keys for Halloween, so I've been living vicariously through youtube videos...but the fact that Gidel just pops up from under the desk to wave his arms around happily is really testing my resolve. D: I'm gonna die when they finally get to do alchemy...)

[milliesnap]

hermitcrossing...?

[pokimoko]

Asexual bird? Please

How about two asexual birds?

[lonelyzarquon]